Table 1.
Diagnoses and procedures recorded in the patient's medical history one month prior to infection, or those that were identified as chronic conditions prior to the infection. Diagnoses and procedures descriptions are provided in international classification of diseases, ninth revision, clinical modification (ICD-9-CM) format [56].
| Non Severe (n = 2401) |
Severe (n = 534) |
All patients |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Male (n =1206) | Female (n = 1195) | Male (n = 295) | Female (n= 239) | (n = 2935) | ||||||
| Diagnoses and procedures | n | % | n | % | n | % | n | % | n | % |
| Unspecified essential hypertension | 586 | 48.59% | 568 | 47.53% | 194 | 65.76% | 176 | 73.64% | 1524 | 51.93% |
| Other and unspecified hyperlipidemia | 419 | 34.74% | 412 | 34.48% | 131 | 44.41% | 115 | 48.12% | 1077 | 36.70% |
| Diabetes mellitus without mention of complication. type ii or unspecified type not stated as uncontrolled | 334 | 27.69% | 268 | 22.43% | 97 | 32.88% | 80 | 33.47% | 779 | 26.54% |
| Anxiety state unspecified | 170 | 14.10% | 378 | 31.63% | 29 | 9.83% | 66 | 27.62% | 643 | 21.91% |
| Unspecified vitamin D deficiency | 152 | 12.60% | 336 | 28.12% | 29 | 9.83% | 45 | 18.83% | 562 | 19.15% |
| Obesity unspecified | 216 | 17.91% | 241 | 20.17% | 40 | 13.56% | 55 | 23.01% | 552 | 18.81% |
| Contact or exposure to other viral diseases | 171 | 14.18% | 201 | 16.82% | 24 | 8.14% | 24 | 10.04% | 420 | 14.31% |
| Urinary incontinence unspecified | 82 | 6.80% | 196 | 16.40% | 46 | 15.59% | 77 | 32.22% | 401 | 13.66% |
| Chronic kidney disease. unspecified | 128 | 10.61% | 138 | 11.55% | 63 | 21.36% | 44 | 18.41% | 373 | 12.71% |
| Osteoarthrosis unspecified whether generalized or localized involving unspecified site | 82 | 6.80% | 201 | 16.82% | 28 | 9.49% | 55 | 23.01% | 366 | 12.47% |
| Hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptoms (LUTS) | 250 | 20.73% | 0 | 0.00% | 87 | 29.49% | 0 | 0.00% | 337 | 11.48% |
| Mixed hyperlipidemia | 140 | 11.61% | 137 | 11.46% | 37 | 12.54% | 25 | 10.46% | 339 | 11.55% |
| Atrial fibrillation | 104 | 8.62% | 96 | 8.03% | 72 | 24.41% | 53 | 22.18% | 325 | 11.07% |
| Unspecified acquired hypothyroidism | 52 | 4.31% | 199 | 16.65% | 16 | 5.42% | 40 | 16.74% | 307 | 10.46% |
| Unspecified cataract | 123 | 10.20% | 108 | 9.04% | 28 | 9.49% | 29 | 12.13% | 288 | 9.81% |
| Absence of chronic comorbidities or comorbidities during the month preceding infection | 146 | 12.11% | 102 | 8.54% | 7 | 2.37% | 9 | 3.77% | 264 | 8.99% |